Speaker: Jeff Holmes, M.D., Ph.D.Professor of Biomedical Engineering & Medicine, University of VirginiaTopic: Scar Formation After Myocardial Infarction: What Happens, Why does it Matter, and What Can We Do about It?"
As the healthcare environment changes, patients increasingly see more personal control in their choice of doctors, therapies, and systems of care. From new models of tele-health to the ubiquitous direct-to-consumer pharmaceutical ads on TV, patients are shifting to a "customer mind-set" when they make health decisions and this has sweeping ramifications for healthcare providers. In … Read more
Speaker: Francis J. Miller, MD, Professor of Medicine, Dept. of Internal Medicine, Division of Cardiology, Duke University School of MedicineTopic: Role of Smooth Muscle Cell NADPH Oxidase in Vascular Disease Information from Dr. Miller on his lecture:The primary goal of my research program is to understand the molecular and cellular mechanisms that contribute to the … Read more
Recent clinical trials have investigated the efficacy of mechanical closure of patent foramen ovale (PFO) for prevention of recurrent stroke. We will review the epidemiological evidence linking PFO and stroke, the methodology and results of clinical trials of secondary stroke prevention in patients with PFO, and the techniques for mechanical closure of PFO. William J. … Read more
Speaker: Chaitanya Madamanchi, MD, UNC Cardiology FellowTopic: Myocardial Strain Imaging
Consumption of dietary fat has been the focus of debate for more than 50 years. Ancel Keys’ diet-heart hypothesis changed the way Americans eat and as a result has left us with significant unintended consequences. Dr. Klett will review the history of the diet-heart hypothesis, the recently discovered unpublished data refuting the diet-heart hypothesis, and … Read more
Speaker: Kristy Red-Horse, PhD, Assistant Professor, Department of Biology, Stanford UniversityTopic: Coronary Artery Development: Transcriptional Regulation of Blood Flow Guided Behaviors
Immune-related adverse events are an unintentional side effect of immune checkpoint inhibitors used for cancer immunotherapy. Immune checkpoint inhibitors upregulate the immune system to prevent tumor evasion and promote destruction of tumor cells. These immune checkpoint inhibitors are effective as noted by the expanding number of FDA-approved drugs in this class and number of indications. … Read more